Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.
Joosten LPT, van Doorn S, van de Ven PM, Köhlen BTG, Nierman MC, Koek HL, Hemels MEW, Huisman MV, Kruip M, Faber LM, Wiersma NM, Buding WF, Fijnheer R, Adriaansen HJ, Roes KC, Hoes AW, Rutten FH, Geersing GJ. Joosten LPT, et al. Among authors: van doorn s, van de ven pm. Circulation. 2024 Jan 23;149(4):279-289. doi: 10.1161/CIRCULATIONAHA.123.066485. Epub 2023 Aug 27. Circulation. 2024. PMID: 37634130 Free article. Clinical Trial.
EGFR Dynamics Change during Activation in Native Membranes as Revealed by NMR.
Kaplan M, Narasimhan S, de Heus C, Mance D, van Doorn S, Houben K, Popov-Čeleketić D, Damman R, Katrukha EA, Jain P, Geerts WJC, Heck AJR, Folkers GE, Kapitein LC, Lemeer S, van Bergen En Henegouwen PMP, Baldus M. Kaplan M, et al. Among authors: van doorn s, van bergen en henegouwen pmp. Cell. 2016 Nov 17;167(5):1241-1251.e11. doi: 10.1016/j.cell.2016.10.038. Epub 2016 Nov 10. Cell. 2016. PMID: 27839865 Free article.
Adaptive Resistance to EGFR-Targeted Therapy by Calcium Signaling in NSCLC Cells.
Mulder C, Prust N, van Doorn S, Reinecke M, Kuster B, van Bergen En Henegouwen P, Lemeer S. Mulder C, et al. Among authors: van doorn s, van bergen en henegouwen p. Mol Cancer Res. 2018 Nov;16(11):1773-1784. doi: 10.1158/1541-7786.MCR-18-0212. Epub 2018 Jul 2. Mol Cancer Res. 2018. PMID: 29967110
Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation: a meta-analysis of individual participant data of four screening studies.
van Doorn S, Geersing GJ, Kievit RF, van Mourik Y, Bertens LC, van Riet EES, Boonman-de Winter LJ, Moons KGM, Hoes AW, Rutten FH. van Doorn S, et al. Among authors: van riet ees, van mourik y. Heart. 2018 Aug;104(15):1236-1237. doi: 10.1136/heartjnl-2017-312781. Epub 2018 Mar 16. Heart. 2018. PMID: 29549089
[Towards 'the best DOAC'?].
van Doorn S, Rutten FH, Geersing GJ. van Doorn S, et al. Ned Tijdschr Geneeskd. 2019 Mar 21;163:D3524. Ned Tijdschr Geneeskd. 2019. PMID: 30945829 Review. Dutch.
63 results